0001181431-13-007057.txt : 20130206 0001181431-13-007057.hdr.sgml : 20130206 20130206101837 ACCESSION NUMBER: 0001181431-13-007057 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130204 FILED AS OF DATE: 20130206 DATE AS OF CHANGE: 20130206 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CROWLEY Richard CENTRAL INDEX KEY: 0001352961 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15313 FILM NUMBER: 13576527 MAIL ADDRESS: STREET 1: IMCLONE SYSTEMS INCORPORATED STREET 2: 180 VARICK STREET, 6TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SAVIENT PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000722104 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 133033811 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 BUSINESS PHONE: 7324189300 MAIL ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 FORMER COMPANY: FORMER CONFORMED NAME: BIO TECHNOLOGY GENERAL CORP DATE OF NAME CHANGE: 19920703 4 1 rrd368988.xml CROWLEY FORM 4 X0306 4 2013-02-04 0 0000722104 SAVIENT PHARMACEUTICALS INC SVNT 0001352961 CROWLEY Richard 400 CROSSING BLVD. 3RD FLOOR BRIDGEWATER NJ 08807 0 1 0 0 EVP, Biopharmaceutical Ops Common Stock $.01 par value per share 2013-02-04 4 S 0 18900 1.01 D 317975 D Common Stock $.01 par value per share 2013-02-04 4 S 0 30000 1.05 D 287975 D These shares were sold automatically pursuant to a binding contract under Rule 10b5-1 of the Securities Exchange Act of 1934 to cover tax withholding obligations in connection with the vesting of restricted stock granted on February 1, 2012. /s/ Philip K. Yachmetz as attorney-in-fact for Richard Crowley 2013-02-06